CrossrefInfokarte
Third-line tocilizumab for refractory pediatric anti-NMDA receptor encephalitis: a single-center case series
Brain and Development · 2026-12 · 48 (6) · 104598
DOI: 10.1016/j.braindev.2026.104598 ↗Abstract
Kein Abstract verfügbar.
EUVIMED